» Articles » PMID: 37537679

Association of Weight-adjusted-waist Index with Non-alcoholic Fatty Liver Disease and Liver Fibrosis: a Cross-sectional Study Based on NHANES

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2023 Aug 3
PMID 37537679
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The purpose of this study was to explore the association of weight-adjusted-waist index (WWI) with non-alcoholic fatty liver disease (NAFLD) and liver fibrosis.

Methods: A cross-sectional study including 6587 participants was conducted in the National Health and Nutrition Examination Survey (NHANES). Multiple linear regression was used to validate the association of WWI with NAFLD and liver fibrosis, and smoothed curve fitting and threshold effect models were used to validate non-linear relationships. Subgroup analyses were used to verify the stability of the relationship between the independent and dependent variables in different populations.

Results: There was a positive association of WWI with NAFLD and liver fibrosis. In the model adjusted for all covariates, the effect values of WWI with NAFLD and liver fibrosis were (OR = 3.44, 95% CI: 3.09-3.82) and (OR = 2.40, 95% CI: 2.05-2.79), respectively. This positive correlation became more significant as WWI increased when WWI was presented in quartiles (P for trend < 0.01). Smoothed curve fitting and threshold effects analysis suggested a non-linear correlation between WWI and NAFLD (LLR < 0.01), with the positive correlation between WWI and NAFLD becoming more significant when WWI was less than 11.44 [5.93 (95% CI: 5.04-6.98)]. However, there was a linear correlation between WWI and liver fibrosis (LLR = 0.291). When subgroup analyses were performed by indicators such as age, race and gender, we found that the positive association between WWI and the dependent variables (NAFLD and liver fibrosis) was more pronounced in white male participants aged < 40 years.

Conclusions: Among adults in the United States, WWI was positively associated with the prevalence of NAFLD and liver fibrosis. Participants with a WWI less than 11.44 should be cautious about the possibility of an increased risk of NAFLD development due to a higher WWI. Meanwhile, white males younger than 40 years of age should be more cautious about the higher risk of NAFLD and liver fibrosis that might be associated with an increased WWI.

Citing Articles

A positive relationship between weight-adjusted waist index and non-alcoholic fatty liver disease: a study on US adolescents.

Cui X, Huang Y, Kang L, Han L, Sun W, Han K Front Med (Lausanne). 2025; 11():1424667.

PMID: 39845834 PMC: 11753237. DOI: 10.3389/fmed.2024.1424667.


Relationship between three body obesity indicators, WWI, BMI, WtHR, and periodontitis.

Chen X, Zeng C, Chen X, Sun J, Jin F, Chen Z Sci Rep. 2025; 15(1):697.

PMID: 39753692 PMC: 11699209. DOI: 10.1038/s41598-024-83963-7.


Weight-adjusted waist index and cardiovascular disease: a population-based study in Ravansar, Iran.

Sadafi S, Azizi A, Shakiba E, Pasdar Y Arch Public Health. 2024; 82(1):219.

PMID: 39568057 PMC: 11577860. DOI: 10.1186/s13690-024-01451-w.


Association between Weight-Adjusted Waist Index and Depression in NAFLD: the modulating roles of sex and BMI.

Zhang J, Wang Y, Ke S, Xie T, Liu L, Fu X BMC Psychiatry. 2024; 24(1):838.

PMID: 39567895 PMC: 11580667. DOI: 10.1186/s12888-024-06308-8.


Correlation between obstructive sleep apnea and weight-adjusted-waist index: a cross-sectional study.

Zhang M, Weng X, Xu J, Xu X Front Med (Lausanne). 2024; 11:1463184.

PMID: 39512613 PMC: 11541712. DOI: 10.3389/fmed.2024.1463184.


References
1.
Mitra S, De A, Chowdhury A . Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol. 2020; 5:16. PMC: 7063528. DOI: 10.21037/tgh.2019.09.08. View

2.
Simon T, Roelstraete B, Khalili H, Hagstrom H, Ludvigsson J . Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut. 2020; 70(7):1375-1382. PMC: 8185553. DOI: 10.1136/gutjnl-2020-322786. View

3.
Vernon G, Baranova A, Younossi Z . Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34(3):274-85. DOI: 10.1111/j.1365-2036.2011.04724.x. View

4.
Kim B, Fung J, Yuen M, Kim S . Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol. 2013; 19(12):1890-900. PMC: 3613104. DOI: 10.3748/wjg.v19.i12.1890. View

5.
Loomba R, Adams L . Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020; 69(7):1343-1352. PMC: 7945956. DOI: 10.1136/gutjnl-2018-317593. View